Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.04.2024 | Case report

Epoprostenol

Refractory bronchospasm and off-label use

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Hammond TC, et al. Refractory Bronchospasm Due to Inhaled Veletri in a Patient With Acute COVID-19 Associated Respiratory Failure. American Journal of Respiratory and Critical Care Medicine 207: May 2023. Available from: URL: https://dx.doi.org/10.1164/ajrccm-conference.2023.B55 [abstract] Hammond TC, et al. Refractory Bronchospasm Due to Inhaled Veletri in a Patient With Acute COVID-19 Associated Respiratory Failure. American Journal of Respiratory and Critical Care Medicine 207: May 2023. Available from: URL: https://​dx.​doi.​org/​10.​1164/​ajrccm-conference.​2023.​B55 [abstract]
Metadaten
Titel
Epoprostenol
Refractory bronchospasm and off-label use
Publikationsdatum
01.04.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-56836-2

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Multiple drugs

Case report

Ondansetron

Case report

Lenvatinib

Case report

Multiple drugs